Matthew J. Price, MD Profile
Matthew J. Price, MD

@matthewjpricemd

Followers
881
Following
216
Media
9
Statuses
65

Director, Cardiac Catheterization Laboratory, Scripps Clinic

La Jolla, CA
Joined August 2013
Don't wanna be here? Send us removal request.
@NEJM
NEJM
1 year
RESHAPE-HF trial: Among patients with at least moderate functional mitral regurgitation, transcatheter valve repair led to a lower rate of heart failure events during 24 months and better health status at 12 months than medical therapy alone. https://t.co/2eaS8ceLPv #ESCardio
6
107
308
@RahulAggarwalMD
Rahul Aggarwal
1 year
Happy to share MDCalc is now hosting the DOAC Score Last year we published a calculator that predicts bleeding among AFib patients. It outperformed HAS-BLED in 4 multinational cohorts An international collaboration w/ @SmithBIDMC @TIMIStudyGroup @rwyeh https://t.co/2DDeRsWZsQ
@RahulAggarwalMD
Rahul Aggarwal
2 years
1/ Our NEW @CircAHA study, simultaneously published with #ESCCongress 🚨 We develop and validate the NEW #DOAC Score ➡️ A bleeding risk score for patients with #afib on DOACs ✅ We find our DOAC Score outperforms prior risk scores, including the HAS-BLED https://t.co/erPUvbA3Cy
4
35
114
@matthewjpricemd
Matthew J. Price, MD
2 years
✅ Live structural heart cases from Scripps Clinic and OUS ✅Educational content for ICs and imagers ✅Workshops for 3D ICE guided LAAO and tricuspid, Watchman FLX PRO, Amulet, complex mitral TEER, TAVR valve selection ✅So. Cal. in February 7-9th! https://t.co/BDO1a4hZXt
0
5
21
@rwyeh
Robert W. Yeh
2 years
PCI is effective at reducing angina when the target coronary lesion is responsible for angina. Sounds obvious, but bears repeating because of the implications: This is a DIAGNOSTIC problem, not a therapeutic one. We don't have a perfect test linking symptoms to disease.
10
58
279
@psorajja
Paul Sorajja
2 years
Dr Suzanne Arnold validates KCCQ for TR therapy! ~2700 pts from @AbbottNews @EdwardsLifesci QOL is highly meaningful for clinical outcomes in TR @JoaoLCavalcante @HamidNadira @MHIF_Heart @nickaram @djc795 @GilbertTangMD @hahn_rt @vonBardelebenRS
0
19
53
@psorajja
Paul Sorajja
2 years
4
13
37
@ajaysmd
Ajay V. Srivastava MD
2 years
Spent the afternoon with @AdonaMedical learning about their novel biatrial shunt pressure sensor & then🍷 with @FudimMarat who flew in from SKorea, nbd. heart failure recovery fellows-field of structural heart failure 🚀 (@AHajduczok @DmitryYaranovMD now u know why I left early:)
1
3
21
@JasonKatzMD
Jason N. Katz
2 years
Incredible talk on creating systems of care in cardiogenic shock by @RolaKhedrakiMD Amazing work by @ScrippsHealth #SCAIShock2023
6
10
46
@ToddNeale
Todd Neale
2 years
"We don’t have that many therapeutic options for these people with drugs and/or devices, so I think there is a lot of opportunity in this population," @FudimMarat says #HFSA2023 @HFSA; commentary from @KSharmaMD
Tweet card summary image
tctmd.com
The trial sets the stage for additional prospective studies of the approach before launching a pivotal trial, Marat Fudim says.
0
4
5
@ziadalinyc
Ziad Ali
2 years
#ILUMIENIV @ #HOTLINE #ESC2023 Take home •OCT resulted in larger MSA than angio with greater stent expansion •OCT led to fewer major dissections, malapposition, tissue protrusion and untreated focal reference disease •OCT reduced angiographic complications 1/18
12
80
227
@CMichaelGibson
C. Michael Gibson MD
2 years
Dr. Paul Tierstein @PaulTeirstein and I discuss the National Board of Physicians and Surgeons @InfoNbpas as an alternate pathway for board certification that is now accepted at 200 hospitals in the country https://t.co/SS2r4Mn63X
11
66
187
@SVRaoMD
Sunil V. Rao
2 years
What a remarkable exchange. The head of ABIM criticizing physicians for taking up hobbies, implying that time away from work is for doing MOC. ABIM seems stunningly out of touch.
@chadinabhan
chadi nabhan MD, MBA, FACP
2 years
This Tue AM, I host the epic discussion btw @AaronGoodman33 and @RichardBaron17 on the MOC of the ABIM exclusively on #HealthcareUnfiltered podcast. This is a clip from the pod that U will NOT want to miss. It all started with a petition, now with >11k signatures. watch it all
24
113
480
@PaulMahoneyMD
Paul Mahoney
2 years
Our article in JACC Int on MitraClip in challenging anatomy in the EXPAND G4 registry ~ in appropriate hands, excellent results seen even in complex pathology Expanding the Spectrum of TEER Suitability: Evidence From the EXPAND G...
3
7
31
@MyJSCAI
MyJSCAI
2 years
📽️ @SCAI / @HRSonline Expert Consensus Statement on Transcatheter #LAAC. Watch KOL discuss the statement now. 💭💡 ➡️ https://t.co/8IqxMxfSIw @AGoldsweig @FaisalMMerchant @docsaw & Matthew Price
0
5
15
@TCTMD
TCTMD
2 years
Latest-Generation MitraClip Devices Make Strides Against Residual MR https://t.co/JSV2yq2dLZ
0
4
3
@crfheart
Cardiovascular Research Foundation
2 years
Good morning from #TVT2023! Live case from ⁦@cliniquepasteur⁩. #TricuspidTEER@didier_tchetche⁩ ⁦@matthewjpricemd⁩ ⁦@HamidNadira⁩ ⁦@psorajja⁩ ⁦@whisenant_brian#CardioEd
1
19
35
@matthewjpricemd
Matthew J. Price, MD
2 years
What a great day of Laminar #leftatrialappendage closure cases at the #ScrippsHealth La Jolla cath lab! What a novel therapy. A special thanks to Jason Rogers. @Drdevignair @VivekReddyMD
4
4
31
@matthewjpricemd
Matthew J. Price, MD
3 years
LAAO with Watchman FLX: Safer! From @jaccjournals https://t.co/KnTWk7Utey #Afib @adnanalkhouli
4
19
60